BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 9494966)

  • 1. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
    Slemp AE; Kirschner RE
    Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic scars and keloids.
    Haverstock BD
    Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scars and keloids.
    Murray JC
    Dermatol Clin; 1993 Oct; 11(4):697-708. PubMed ID: 8222353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
    Wolfram D; Tzankov A; Pülzl P; Piza-Katzer H
    Dermatol Surg; 2009 Feb; 35(2):171-81. PubMed ID: 19215252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of keloids and hypertrophic scars.
    Juckett G; Hartman-Adams H
    Am Fam Physician; 2009 Aug; 80(3):253-60. PubMed ID: 19621835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperplastic scars and keloids. Part I: basics and prevention].
    Baisch A; Riedel F
    HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of hypertrophic/keloid scarring.
    Thomas DW; Hopkinson I; Harding KG; Shepherd JP
    Int J Oral Maxillofac Surg; 1994 Aug; 23(4):232-6. PubMed ID: 7798696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment.
    Berman B; Maderal A; Raphael B
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S3-S18. PubMed ID: 27347634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and management of hypertrophic scars and keloids after burns in children.
    Berman B; Viera MH; Amini S; Huo R; Jones IS
    J Craniofac Surg; 2008 Jul; 19(4):989-1006. PubMed ID: 18650721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aetiology and management of hypertrophic scars and keloids.
    O'Sullivan ST; O'Shaughnessy M; O'Connor TP
    Ann R Coll Surg Engl; 1996 May; 78(3 ( Pt 1)):168-75. PubMed ID: 8779496
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic or keloid scars?
    McGrouther DA
    Eye (Lond); 1994; 8 ( Pt 2)():200-3. PubMed ID: 7958022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.